Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Profit from core business operations before interest and taxes
Latest
$-300.10M
↓ 42% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-211.31M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-300.10M | +39.7% |
| 2024 | $-497.88M | -30.8% |
| 2023 | $-380.50M | -29.6% |
| 2022 | $-293.57M | -21.1% |
| 2021 | $-242.48M | -17.5% |
| 2020 | $-206.32M | -117.2% |
| 2019 | $-94.97M | -134.8% |
| 2018 | $-40.46M | -26.9% |
| 2017 | $-31.89M | -27.6% |
| 2016 | $-24.98M | - |